Clinical Trials Directory

Trials / Completed

CompletedNCT02391090

FeNO After Hypoxia in Asthma Patients

Effects of Intermittent Hypoxia on the Asthmatic Inflammation of Asthma Patients - a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Stable Asthma patients (GINA 1-2) stay 6 days in a row for 4 hours per day in a hypoxic chamber simulating 2800m above sea level. Study participants will be blinded to the treatment given and divided into a hypoxic and a sham group (about 360m above sea level). Effects of this intermittent hypoxia on the asthmatic inflammation of these patients will be measured. The primary endpoint is the change in forced exhaled nitric oxide (FeNO) before and after the study. Secondary endpoints include blood parameters, lung function testing and questionnaires.

Conditions

Interventions

TypeNameDescription
DEVICEhypoxia in hypoxic chamberIntervention lasts 4 hours per day for 6 days in a row.
DEVICEsham hypoxia in hypoxic chamberIntervention lasts 4 hours per day for 6 days in a row.
PROCEDUREPulse oximetryPulse oximetry will be performed hourly during sessions in the hypoxic chamber for safety reasons.
OTHERAsthma and Quality of Life QuestionnairesBefore every session in the hypoxic chamber as well as on the day after the last session will be completed.
PROCEDURELung function testingOn the day of the first session in the hypoxic chamber as well as on the day after the last session lung function testing will be performed.
PROCEDUREBlood takingOn the day of the first session in the hypoxic chamber as well as on the day after the last session blood samples will be taken.
PROCEDUREFeNO measurementBefore every session in the hypoxic chamber as well as on the day after the last session FeNO (forced exhaled nitric oxide) measurement will be performed.

Timeline

Start date
2014-11-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2015-03-18
Last updated
2015-03-18

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02391090. Inclusion in this directory is not an endorsement.